OptiNose (OPTN) Competitor Comparison
We are evaluating the key criteria listed to compare OptiNose (OPTN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
33 / 55Gross Profits
26 / 40Total Revenue
38 / 51EBITDA
44 / 54Free Cashflow
45 / 55Quick Ratio
49 / 55Earnings per Share
24 / 55Dividend yield
0 / 5Total Cash
35 / 55Performance 3 years
31 / 55Performance 5 years
44 / 55Performance 10 years
48 / 55Linearity 3 years
24 / 55Linearity 5 years
45 / 55Linearity 10 years
42 / 55Total Rank
23 / 55Dividend Rank
29 / 55Valuation Rank
48 / 55Piotroski Rank
29 / 55Muliplier Rank
31 / 55Market Capitalization - OPTN ranking 33 / 55
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.